News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Buy call on Boeing ahead of an expected cash-flow inflection over the next 12–18 months.
  • FAA approval of the 737 MAX 7 and new defense awards provide near-term catalysts for Boeing.
  • Algonquin Power's move to a regulated-only profile stabilizes cash flow and underpins a 4.6% yield.
  • Technical setup and valuation near support make Algonquin a measured swing-long with a defined stop.
  • VXUS is pitched as a tactical buy for international diversification, covering 8,700+ non-U.S. stocks and a 2.5% yield.
  • VXUS's bullish momentum and roughly 4.6M average daily volume support trade execution for retirement portfolios.

Latest Articles

SoundHound to Buy LivePerson; Stock Drops After Deal Announcement

SoundHound to Buy LivePerson; Stock Drops After Deal Announcement

SoundHound AI announced a definitive agreement to acquire LivePerson in a deal that values LivePerson’s equity at $43 million and implies an enterprise value of $250 million. Shares of SoundHound fell 4.3% on the announcement. The companies expect to combine voice AI and digital engagement capabilities to serve enterprise customers worldwide, with …

Zions: NII Momentum + Buyback = Re-rating Opportunity into 2026

Zions: NII Momentum + Buyback = Re-rating Opportunity into 2026

Zions Bancorporation is showing the building blocks for a 2026 re-rating: rising yields should lift net interest income, recent corporate actions (a $75M repurchase and steady dividend) support per-share cash flow, and the stock trades at a modest P/E and low P/B. We lay out a long trade with entry at $62.00, stop at $57.00 and a primary target of …

New York Attorney General Sues Coinbase and Gemini Over Prediction Markets

New York Attorney General Sues Coinbase and Gemini Over Prediction Markets

The New York Attorney General has brought civil actions against Coinbase Financial Markets and Gemini Titan, asserting their prediction market products operate as illegal gambling under state law. The complaints claim both platforms failed to secure appropriate licenses and allowed access to users under 21, and the AG is seeking disgorgement, trebl…

Iran Conditions Participation in Islamabad Talks on U.S. Port Blockade

Iran Conditions Participation in Islamabad Talks on U.S. Port Blockade

Iran has signaled it will not publicly confirm attendance at a planned round of talks in Islamabad unless the United States lifts its blockade of Iranian ports. Tehran initially told mediators it would send a delegation for talks on Tuesday but later qualified that position by linking participation to the removal of the blockade. Pakistan is pressi…

Table for Mom: OpenTable Launches Mother’s Day Dining Trends and Canada’s Top 100 Brunch and Lunch Restaurants for 2026

Table for Mom: OpenTable Launches Mother’s Day Dining Trends and Canada’s Top 100 Brunch and Lunch Restaurants for 2026

OpenTable, part of Booking Holdings, Inc., announced its annual Top 100 Brunch and Lunch Restaurants in Canada for 2026 and shared consumer trends for Mother’s Day dining, revealing that 65% of Canadians consider dining out an important part of their celebration. The data highlights evolving celebration styles including solo dining, larger family g…

Merck Shares Slip After Phase 3 Kidney Cancer Trial Fails to Meet Endpoints

Merck Shares Slip After Phase 3 Kidney Cancer Trial Fails to Meet Endpoints

Merck & Co. stock declined after the company and Eisai reported that their Phase 3 LITESPARK-012 study in advanced clear cell renal cell carcinoma did not reach its primary endpoints. The trial compared two experimental combination regimens to the established Keytruda plus Lenvima regimen and found no superior progression-free survival or overall s…

Intuitive Machines: Buy the Moon-Infra Transition, Trim at Proof Points

Intuitive Machines: Buy the Moon-Infra Transition, Trim at Proof Points

Intuitive Machines (LUNR) is trading near $28.41 after a run from a $6.75 52-week low as investor focus shifts from a single lunar mission to recurring cislunar services. The company shows early revenue upside via government and commercial lunar contracts (including a $180.4 million award), strong liquidity per share, but valuation metrics (P/S ~20…

U.S. General Says THAAD Batteries Remain in South Korea Despite Earlier Reports

U.S. General Says THAAD Batteries Remain in South Korea Despite Earlier Reports

The commander of U.S. Forces in Korea told a Senate committee that Terminal High Altitude Area Defense (THAAD) systems have not been relocated from South Korea to the Middle East, though some radars and munitions were moved forward during operations tied to U.S. strikes on Iran. He said THAAD batteries currently remain on the peninsula and are expe…

Trump Says He Will 'Remember' Companies That Opt Not to Seek Tariff Refunds

Trump Says He Will 'Remember' Companies That Opt Not to Seek Tariff Refunds

President Donald Trump told CNBC he will "remember" U.S. companies that have not pursued refunds after a court found last year’s global tariffs unlawful. His remarks came as U.S. Customs and Border Protection began accepting electronic refund applications through a new system and a federal judge ordered the agency to report on the portal's first ph…

Bright Horizons: Re-Rating Setup as Macro and Fundamentals Align

Bright Horizons: Re-Rating Setup as Macro and Fundamentals Align

Bright Horizons (BFAM) looks positioned for a re-rating. At roughly $85, the stock trades at ~24x earnings with $258M in trailing free cash flow and an enterprise value near $5.5B. Improving technicals, manageable leverage and reopening tailwinds create a clear risk-reward for a mid-term trade targeting $110 over the next 45 trading days, with a $7…